CAMK2G and catecholaminergic polymorphic ventricular tachycardia: Inhibition of Ca2+/calmodulin‐dependent protein kinase type II (CaMKII) prevents arrhythmias in murine models of catecholaminergic polymorphic ventricular tachycardia (CPVT).